Article: Solvay Subscribes to a CustomSuite of Gene Logic's BioExpress System.

Business Editors/Health/Medical Writers

BIOWIRE2K

GAITHERSBURG, Md.--(BUSINESS WIRE)--May 28, 2003

Gene Logic Inc. (Nasdaq:GLGC) today announced that Solvay Pharmaceuticals ("Solvay"), a division of Solvay S.A., an international chemical and pharmaceutical group based in Brussels, has subscribed to a CustomSuite product from Gene Logic's BioExpress(TM) System.

Solvay will apply this data resource to selected areas of their target discovery research efforts. Financial details of the multiyear subscription agreement were not disclosed.

The subscription agreement gives Solvay researchers access to a customized information ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!